PITX1, a specificity determinant in the HIF-1α-mediated transcriptional response to hypoxia

Cell Cycle

Volumn 13, Issue 24, 2014, Pages 3878-3891

  Mudie, Sharon ^a   Bandarra, Daniel ^a   Batie, Michael ^a   Biddlestone, John ^a   Moniz, Sonia ^a   Ortmann, Brian ^a   Shmakova, Alena ^a   Rocha, Sonia ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

ChIP; HIF; HIF 1 ; Histone methylation; Hypoxia; JMJC; JMJD2B; PITX1; Transcription

Indexed keywords

HETERODIMER; HISTONE DEMETHYLASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; JMJD1B ENZYME; JMJD2A ENZYME; JMJD2B ENZYME; JMJD2C ENZYME; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PITX1; UNCLASSIFIED DRUG; ARNT PROTEIN, HUMAN; HOMEOBOX PROTEIN PITX1; MESSENGER RNA; PAIRED BOX TRANSCRIPTION FACTOR; PROTEIN BINDING;

ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; ARTICLE; AUTOPHAGY; BLEACHING; BREAST CANCER CELL LINE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL HYPOXIA; CELL PROLIFERATION; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; CHROMATIN STRUCTURE; FLOW CYTOMETRY; GENE EXPRESSION; HEK293 CELL LINE; HELA CELL LINE; HISTONE METHYLATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LUCIFERASE ASSAY; NUCLEOTIDE SEQUENCE; PROMOTER REGION; U2OS CELL LINE; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; CHEMISTRY; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; RNA INTERFERENCE; TUMOR CELL LINE;

ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; CELL HYPOXIA; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; HEK293 CELLS; HELA CELLS; HISTONE DEMETHYLASES; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; PAIRED BOX TRANSCRIPTION FACTORS; PHOTOBLEACHING; PROTEIN BINDING; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC;

EID: 84920683806     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/15384101.2014.972889     Document Type: Article

References (39)

1. Kenneth NS, Rocha S. Regulation of gene expression by hypoxia. Biochem J 2008; 414:19-29; PMID:18651837; http://dx.doi.org/10.1042/BJ20081055
2. Fandrey J, Gorr TA, Gassmann M. Regulating cellular oxygen sensing by hydroxylation. Cardiovasc Res 2006; 71:642-51; PMID:16780822; http://dx.doi.org/10.1016/j.cardiores.2006.05.005
3. Lando D, Peet DJ, Whelan DA, Gorman JJ, Whitelaw ML. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 2002; 295:858-61; PMID:11823643; http://dx.doi.org/10.1126/science.1068592
4. Ruas JL, Poellinger L, Pereira T. Functional analysis of hypoxia-inducible factor-1 alpha-mediated transactivation. Identification of amino acid residues critical for transcriptional activation andor interaction with CREB-binding protein. J Biol Chem 2002; 277:38723-30; PMID:12133832; http://dx.doi.org/10.1074/jbc.M205051200
5. Melvin A, Rocha S. Chromatin as an oxygen sensor and active player in the hypoxia response. Cell Signal 2012; 24:35-43; PMID:21924352; http://dx.doi.org/10.1016/j.cellsig.2011.08.019
6. Wenger RH, Stiehl DP, Camenisch G. Integration of oxygen signaling at the consensus HRE. Sci STKE 2005; 2005:re12; PMID:16234508
7. Semenza GL. Oxygen sensing, homeostasis, and disease. N Engl J Med 2011; 365:537-47; PMID:21830968; http://dx.doi.org/10.1056/NEJMra1011165
8. Moniz S, Biddlestone J, Rocha S. Grow(2): The HIF system, energy homeostasis and the cell cycle. Histol Histopathol 2014; PMID:24407868
9. Knosel T, Chen Y, Hotovy S, Settmacher U, Altendorf-Hofmann A, Petersen I. Loss of desmocollin 1-3 and homeobox genes PITX1 and CDX2 are associated with tumor progression and survival in colorectal carcinoma. Int J Colorectal Dis 2012; 27:1391-9; PMID:22438068; http://dx.doi.org/10.1007/s00384-012-1460-4
10. Davidson B, Stavnes HT, Risberg B, Nesland JM, Wohlschlaeger J, Yang Y, Shih IeM, Wang TL. Gene expression signatures differentiate adenocarcinoma of lung and breast origin in effusions. Hum Pathol 2012; 43:684-94; PMID:21937081; http://dx.doi.org/10.1016/j.humpath.2011.06.015
11. Tremblay JJ, Goodyer CG, Drouin J. Transcriptional properties of Ptx1 and Ptx2 isoforms. Neuroendocrinology 2000; 71:277-86; PMID:10859489; http://dx. doi.org/10.1159/000054547
12. Poulin G, Lebel M, Chamberland M, Paradis FW, Drouin J. Specific protein-protein interaction between basic helix-loop-helix transcription factors and homeoproteins of the Pitx family. Mol Cell Biol 2000; 20:4826-37; PMID:10848608; http://dx.doi.org/10.1128/MCB.20.13.4826-4837.2000
13. Kolfschoten IG, van Leeuwen B, Berns K, Mullenders J, Beijersbergen RL, Bernards R, Voorhoeve PM, Agami R. A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicity. Cell 2005; 121:849-58; PMID:15960973; http://dx.doi.org/10.1016/j.cell.2005.04.017
14. Qi DL,Ohhira T, FujisakiC, Inoue T, Ohta T, OsakiM, Ohshiro E, Seko T, Aoki S, Oshimura M, et al. Identification of PITX1 as a TERT suppressor gene located on human chromosome 5.Mol Cell Biol 2011; 31:1624-36; PMID:21300782; http://dx.doi.org/10.1128/MCB.00470-10
15. Tsukada Y, Fang J, Erdjument-Bromage H, Warren ME, Borchers CH, Tempst P, Zhang Y. Histone demethylation by a family of JmjC domain-containing proteins. Nature 2006; 439:811-6; PMID:16362057; http://dx.doi.org/10.1038/nature04433
16. Chen Z, Zang J, Whetstine J, Hong X, Davrazou F, Kutateladze TG, Simpson M, Mao Q, Pan CH, Dai S, et al. Structural insights into histone demethylation by JMJD2 family members. Cell 2006; 125:691-702; PMID:16677698; http://dx.doi.org/10.1016/j.cell.2006.04.024
17. Whetstine JR, Nottke A, Lan F, Huarte M, Smolikov S, Chen Z, Spooner E, Li E, Zhang G, Colaiacovo M, et al. Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell 2006; 125:467-81; PMID:16603238; http://dx.doi.org/10.1016/j.cell.2006.03.028
18. Shmakova A, Batie M, Druker J, Rocha S. Chromatin and oxygen sensing in the context of JmjC histone demethylases. Biochem J 2014; 462:385-95; PMID: 25145438; http://dx.doi.org/10.1042/BJ20140754
19. Yang J, Jubb AM, Pike L, Buffa FM, TurleyH, Baban D, Leek R, Gatter KC, Ragoussis J, Harris AL. The histone demethylase JMJD2B is regulated by estrogen receptor alpha and hypoxia, and is a key mediator of estrogen induced growth. Cancer Res 2010; 70:6456-66; PMID:20682797; http://dx.doi.org/10.1158/0008-5472.CAN-10-0413
20. Shi L, Sun L, Li Q, Liang J, Yu W, Yi X, Yang X, Li Y, Han X, Zhang Y, et al. Histone demethylase JMJD2B coordinates H3K4H3K9 methylation and promotes hormonally responsive breast carcinogenesis. Proc Natl Acad Sci U S A 2011; 108:7541-6; PMID:21502505; http://dx.doi.org/10.1073/pnas.1017374108
21. Fu L, Chen L, Yang J, Ye T, Chen Y, Fang J. HIF-1alpha-induced histone demethylase JMJD2B contributes to the malignant phenotype of colorectal cancer cells via an epigenetic mechanism. Carcinogenesis 2012; 33:1664-73; PMID:22745382; http://dx.doi. org/10.1093/carcin/bgs217
22. Berry WL, Janknecht R. KDM4JMJD2 histone demethylases: epigenetic regulators in cancer cells. Cancer Res 2013; 73:2936-42; PMID:23644528; http://dx. doi.org/10.1158/0008-5472.CAN-12-4300
23. Kooistra SM, Helin K. Molecular mechanisms and potential functions of histone demethylases. Nat Rev Mol Cell Biol 2012; 13:297-311; PMID:22473470
24. Gu Y, Di WL, Kelsell DP, Zicha D. Quantitative fluorescence resonance energy transfer (FRET) measurement with acceptor photobleaching and spectral unmixing. J Microsc 2004; 215:162-73; PMID:15315503; http://dx.doi.org/10.1111/j.0022-2720.2004.01365.x
25. Rocha S. Gene regulation under low oxygen: holding your breath for transcription. Trends Biochem Sci 2007; 32:389-97; PMID:17624786; http://dx.doi.org/10.1016/j.tibs.2007.06.005
26. Szeto DP, Rodriguez-Esteban C, Ryan AK, O'Connell SM, Liu F, Kioussi C, Gleiberman AS, Izpisúa-Belmonte JC, Rosenfeld MG. Role of the Bicoid-related homeodomain factor Pitx1 in specifying hindlimb morphogenesis and pituitary development. Genes Dev 1999; 13:484-94; PMID:10049363; http://dx.doi.org/10.1101/gad.13.4.484
27. Tremblay JJ, Marcil A, Gauthier Y, Drouin J. Ptx1 regulates SF-1 activity by an interaction that mimics the role of the ligand-binding domain. Embo J 1999; 18:3431-41; PMID:10369682; http://dx.doi.org/10.1093/emboj/18.12.3431
28. Tremblay JJ, Drouin J. Egr-1 is a downstream effector of GnRH and synergizes by direct interaction with Ptx1 and SF-1 to enhance luteinizing hormone beta gene transcription. Mol Cell Biol 1999; 19:2567-76; PMID:10082522
29. Tremblay JJ, Lanctot C, Drouin J. The pan-pituitary activator of transcription, Ptx1 (pituitary homeobox 1), acts in synergy with SF-1 and Pit1 and is an upstream regulator of the Lim-homeodomain gene Lim3Lhx3. Mol Endocrinol 1998; 12:428-41; PMID:9514159; http://dx.doi.org/10.1210/mend.12.3.0073
30. Bersten DC, Sullivan AE, Peet DJ, Whitelaw ML. bHLH-PAS proteins in cancer. Nat Rev Cancer 2013; 13:827-41; PMID:24263188; http://dx.doi.org/10.1038/nrc3621
31. Davidson B, Stavnes HT, Holth A, Chen X, Yang Y, Shih Ie M, Wang TL. Gene expression signatures differentiate ovarianperitoneal serous carcinoma from breast carcinoma in effusions. J Cell Mol Med 2011; 15:535-44; PMID:20132413; http://dx.doi.org/10.1111/j.1582-4934.2010.01019.x
32. Stender JD, Stossi F, Funk CC, Charn TH, Barnett DH, Katzenellenbogen BS. The estrogen-regulated transcription factor PITX1 coordinates gene-specific regulation by estrogen receptor-alpha in breast cancer cells. Mol Endocrinol 2011; 25:1699-709; PMID: 21868451; http://dx.doi.org/10.1210/me.2011-0102
33. Semenza GL. Molecular mechanisms mediating metastasis of hypoxic breast cancer cells. Trends Mol Med 2012; 18:534-43; PMID:22921864; http://dx.doi.org/10.1016/j.molmed.2012.08.001
34. Keith B, Johnson RS, Simon MC. HIF1alpha and HIF2alpha: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer 2012; 12:9-22.
35. Fodor BD, Kubicek S, YonezawaM, O'Sullivan RJ, Sengupta R, Perez-Burgos L, Opravil S, Mechtler K, Schotta G, Jenuwein T. Jmjd2b antagonizes H3K9 trimethylation at pericentric heterochromatin in mammalian cells.Genes Dev 2006; 20:1557-62; PMID:16738407; http://dx.doi. org/10.1101/gad.388206
36. Melvin A, Mudie S, Rocha S. The chromatin remodeler ISWI regulates the cellular response to hypoxia: role of FIH. Mol Biol Cell 2011; 22:4171-81; PMID:21900490; http://dx.doi.org/10.1091/mbc.E11-02-0163
37. van Uden P, Kenneth NS, Rocha S. Regulation of hyp-oxia-inducible factor-1alpha by NF-kappaB. The Biochemical journal 2008; 412:477-84; PMID:18393939; http://dx.doi.org/10.1042/BJ20080476
38. Allan C, Burel JM, Moore J, Blackburn C, Linkert M, Loynton S, Macdonald D, Moore WJ, Neves C, Patterson A, et al. OMERO: flexible, model-driven data management for experimental biology. Nat Methods 2012; 9:245-53; PMID:22373911; http://dx.doi.org/10.1038/nmeth.1896
39. Kenneth NS, Mudie S, van Uden P, Rocha S. SWISNF regulates the cellular response to hypoxia. J Biol Chem 2009; 284:4123-31; PMID:19097995; http://dx.doi. org/10.1074/jbc.M808491200